---
title: "Braveheart Bio director Vineeta Agarwala files initial beneficial ownership statement"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295976985.md"
description: "Braveheart Bio director Vineeta Agarwala filed an initial Form 3 with the SEC, reporting indirect ownership of 10,232,420 common shares. The filing was published via EDGAR on August 14, 2026."
datetime: "2026-08-14T21:05:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295976985.md)
  - [en](https://longbridge.com/en/news/295976985.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295976985.md)
generator: "portal-rs"
---

# Braveheart Bio director Vineeta Agarwala files initial beneficial ownership statement

-   Director Vineeta Agarwala filed an initial Form 3 for Braveheart Bio, reporting indirect ownership of 10,232,420 common shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Braveheart Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002003663-26-000005), on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BRVE.US](https://longbridge.com/en/quote/BRVE.US.md)

## Related News & Research

- [TipRanks Analyst Salveen Richter Reiterates Buy on Braveheart Bio, Sets $48 12-Month Target on Strong HCM Opportunity for Lead Asset BHB-1893](https://longbridge.com/en/news/297471640.md)
- [Braveheart Bio (NASDAQ:BRVE) Rating Increased to Strong-Buy at The Goldman Sachs Group](https://longbridge.com/en/news/297636931.md)
- [U.S. RESEARCH ROUNDUP-Adobe, Braveheart Bio, CACI International](https://longbridge.com/en/news/297477215.md)
- [OrbiMed Advisors acquires 1.940.000 Braveheart Bio common shares worth $ 34,92 juta](https://longbridge.com/en/news/295583346.md)
- [AH Bio Fund IV Discloses Investment at Braveheart Bio with 11.4% Stake](https://longbridge.com/en/news/295977626.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**